Simvastatin improves endothelial function in patents with subclinical hypothyroidism

Heart and Vessels

Volumn 22, Issue 2, 2007, Pages 88-93

  Duman, Dursun ^a,c   Sahin, Sinan ^b   Esertas, Kenan ^a   Demirtunc, Refik ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b Siyami Ersek Cardiovascular Training and Research Hospital   (Turkey)

^c Agaoglu My Country Sitesi D10 1   (Turkey)

Author keywords

Endothelial dysfunction; Levothyroxine; Simvastatin; Subclinical hypothyroidism

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATINE KINASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVOTHYROXINE; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TEFOR; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; DRUG WITHDRAWAL; DYSLIPIDEMIA; ENDOTHELIUM LESION; GLUCOSE BLOOD LEVEL; HASHIMOTO DISEASE; HUMAN; HYPEREMIA; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; LIPID ANALYSIS; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SUBCLINICAL HYPOTHYROIDISM; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANALYSIS OF VARIANCE; CHOLESTEROL; DYSLIPIDEMIAS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOTHYROIDISM; PROSPECTIVE STUDIES; SIMVASTATIN; THYROXINE; TRIGLYCERIDES; VASODILATION;

EID: 34047166993     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-006-0950-0     Document Type: Article

References (32)

1. M Helfand CC Redfern 1998 Clinical guideline, part 2. Screening for thyroid disease: An update. American College of Physicians Ann Intern Med 129 144-158 1:STN:280:DyaK1czhvVWqug%3D%3D
2. GJ Canaris NR Manowitz G Mayor EC Ridgway 2000 The Colorado Thyroid Disease Prevalence Study Arch Intern Med 160 526-534 10.1001/ archinte.160.4.526 1:STN:280:DC%2BD3c7lvVansg%3D%3D
3. JG Hollowell NW Staehling WD Flanders 2002 Serum TSH, T4 and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) J Clin Endocrinol Metab 87 489-499 10.1210/jc.87.2.489 1:CAS:528:DC%2BD38XhsVSjtbw%3D
4. CT Sawin WP Castelli JM Hershman P McNamara P Bacharach 1985 The aging thyroid: Thyroid deficiency in the Framingham Study Arch Intern Med 145 1386-1388 10.1001/archinte.145.8.1386 1:STN:280:BiqB2sfltVc%3D
5. JV Parle JA Franklyn KW Cross SC Jones MC Sheppard 1991 Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom Clin Endocrinol (Oxf) 34 77-83 1:STN:280:By6C28fktFQ%3D
6. DS Cooper R Halpern LC Wood AA Levin EC Ridgway 1984 L-thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial Ann Intern Med 101 18-24 1:STN:280:BiuB38bmsVU%3D
7. F Monzani N Caraccio P Del Guerra A Casolaro E Ferrannini 1999 Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: Beneficial effect of L-T4 replacement therapy Clin Endocrinol (Oxf) 51 237-242 10.1046/j.1365-2265.1999.00790.x 1:CAS:528:DyaK1MXlvFGls70%3D
8. M Tièche GA Lupi F Gutzwiller PJ Grob H Studer H Bürgi 1981 Borderline low thyroid function and thyroid autoim-munity. Risk factors for coronary heart disease? Br Heart J 46 202-206
9. JP Walsh AP Bremner MK Bulsara P O'Leary PJ Leedman P Feddema V Michelangeli 2005 Subclinical thyroid dysfunction as a risk factor for cardiovascular disease Arch Intern Med 165 2467-2472 10.1001/ archinte.165.21.2467
10. MP Vanderpump WM Tunbridge JM French 1996 The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community Thyroid 6 155-160 1:STN:280:BymH3svjsFc%3D
11. AE Hak HA Pols TJ Visser HA Drexhage A Hofman JC Witteman 2000 Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly woman: The Rotterdam Study Ann Intern Med 132 270-278 1:STN:280:DC%2BD3c7jt1egsg%3D%3D
12. M Imaizumi M Akahoshi S Ichimaru 2004 Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism J Clin Endocrinol Metab 89 7 3365-3370 10.1210/jc.2003-031089 1:CAS:528:DC%2BD2cXlslegsbs%3D
13. GJ Kahaly 2000 Cardiovascular and atherogenic aspects of subclinical hypothyroidism Thyroid 10 665-679 10.1089/10507250050137743 1:STN:280:DC%2BD3cvmt1alsg%3D%3D
14. DC Bauer B Ettinger WS Browner 1998 Thyroid functions and serum lipids in older women: A population-based study Am J Med 104 546-551 10.1016/ S0002-9343(98)00116-8 1:STN:280:DyaK1czjslCktg%3D%3D
15. S Miura M Iitaka H Yoshimura 1994 Disturbed lipid metabolism in patients with subclinical hypothyroidism: Effect of L-thyroxine therapy Intern Med 33 413-417 1:STN:280:ByqD3snpsFQ%3D
16. C Meier JJ Staub CB Roth M Guglielmetti M Kunz AR Miserez J Drewe P Huber R Herzog B Muller 2001 TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study) J Clin Endocrinol Metab 86 10 4860-4866 10.1210/jc.86.10.4860 1:CAS:528:DC%2BD3MXptVarsbo%3D
17. Z Efstathiadou S Bitsis HJ Milionis 2001 Lipid profile in subclinical hypothyroidism: Is L-thyroxine substitution beneficial?. European Journal of Endocrinology 145 705-710 10.1530/eje.0.1450705 1:CAS:528:DC%2BD3MXpt1Ght7o%3D
18. R Fathi B Haluska N Isbel L Short TH Marwick 2004 The relative importance of vascular structure and function in predicting cardiovascular events J Am Coll Cardiol 18 43 4 616-623 10.1016/ j.jacc.2003.09.042
19. AL Moens I Goovaerts MJ Claeys CJ Vrints 2005 Flow-mediated vasodilation: A diagnostic instrument, or an experimental tool? Chest 127 2254-2263 10.1378/chest.127.6.2254
20. J Lekakis C Papamichael M Alevizaki G Piperingos P Marafelia J Mantzos 1997 Flow mediated, endothelium-dependent vasodilatation is impaired in subject with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values Thyroid 7 411-444 1:STN:280:ByiA28bnslU%3D
21. S Taddei N Caraccio A Virdis 2003 Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: Beneficial effect of levotiroxine therapy J Clin Endocrinol Metab 88 3731-3737 10.1210/ jc.2003-030039 1:CAS:528:DC%2BD3sXmsFOktL4%3D
22. O Tamai H Matsuoka H Itabe Y Wada K Kohno T Imaizumi 1997 Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans Circulation 95 76-82 1:STN:280:ByiC2cjmsVw%3D
23. G O'Driscoll D Green RR Taylor 1997 Simvastatin, an HMG-coenzyme: A reductase inhibitor, improves endothelial function within 1 month Circulation 95 1126-1131
24. CB Treasure JL Klein WS Weintraub 1995 Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease N Engl J Med 332 481-487 10.1056/ NEJM199502233320801 1:STN:280:ByqC3s7ps1M%3D
25. H Omori H Nagashima Y Tsurumi 2002 Direct in vivo evidence of a vascular statin: A single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects Br J Clin Pharmacol 54 395-399 10.1046/j.1365-2125.2002.01677.x 1:CAS:528:DC%2BD38XpsVWitLw%3D
26. RS Rosenson 1999 Non-lipid-lowering effects of statins on atherosclerosis Curr Cardiol Rep 1 225-232 1:STN:280:DC%2BD3M%2FlsF2qsA%3D%3D
27. S Wolfrum KS Jensen J Liao 2003 Endothelium-dependent effects of statins Arterioscler Thromb Vasc Biol 23 729-736 10.1161/ 01.ATV.0000063385.12476.A7 1:CAS:528:DC%2BD3sXjtlaktLw%3D
28. MC Corretti TJ Anderson EJ Benjamin 2002 International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery J Am Coll Cardiol 39 257-265 10.1016/S0735-1097(01)01746-6
29. B Biondi EA Palmieri G Lombardi S Fazio 2002 Effects of subclinical hypothyroid dysfunction on the heart Ann Intern Med 137 904-914
30. M Perk O Neill 1997 The effect of hormone therapy on angiographic coronary artery disease progression Can J Cardiol 13 273-276 1:CAS:528:DyaK2sXivVehsLk%3D
31. N Rodondi AB Newman E Vittinghoff N de Rekeneire S Satterfield TB Harris DC Bauer 2005 Subclinical Hypothyroidism and the Risk of Heart Failure, Other Cardiovascular Events, and Death Arch Intern Med 165 2460-2466 10.1001/archinte.165.21.2460
32. T Neunteufl R Katzenschlager A Hassan 1997 Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease Atherosclerosis 129 111-118 10.1016/S0021-9150(96)06018-2 1:CAS:528:DyaK2sXhsFKmsb8%3D